Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID |
|---|---|---|---|---|---|
| 1 | Bladder cancer 💬 1 gene, 1 drug (DrugBank) and 5 diseases |
MMP9 [1] MMP9 💬
|
Andecaliximab Andecaliximab 💬
| Andecaliximab | 046 [5] 46, 96, 97, 272, 299 💬
|
| 2 | Diabetic cardiomyopathy 💬 1 gene, 1 drug (DrugBank) and 5 diseases |
MMP9 [1] MMP9 💬
|
Andecaliximab Andecaliximab 💬
| Andecaliximab | 046 [5] 46, 96, 97, 272, 299 💬
|
| 3 | Estrogen signaling pathway 💬 1 gene, 1 drug (DrugBank) and 5 diseases |
MMP9 [1] MMP9 💬
|
Andecaliximab Andecaliximab 💬
| Andecaliximab | 046 [5] 46, 96, 97, 272, 299 💬
|
| 4 | Fluid shear stress and atherosclerosis 💬 1 gene, 1 drug (DrugBank) and 5 diseases |
MMP9 [1] MMP9 💬
|
Andecaliximab Andecaliximab 💬
| Andecaliximab | 046 [5] 46, 96, 97, 272, 299 💬
|
| 5 | Hepatitis B 💬 1 gene, 1 drug (DrugBank) and 5 diseases |
MMP9 [1] MMP9 💬
|
Andecaliximab Andecaliximab 💬
| Andecaliximab | 046 [5] 46, 96, 97, 272, 299 💬
|
| 6 | IL-17 signaling pathway 💬 1 gene, 1 drug (DrugBank) and 5 diseases |
MMP9 [1] MMP9 💬
|
Andecaliximab Andecaliximab 💬
| Andecaliximab | 046 [5] 46, 96, 97, 272, 299 💬
|
| 7 | Leukocyte transendothelial migration 💬 1 gene, 1 drug (DrugBank) and 5 diseases |
MMP9 [1] MMP9 💬
|
Andecaliximab Andecaliximab 💬
| Andecaliximab | 046 [5] 46, 96, 97, 272, 299 💬
|
| 8 | Lipid and atherosclerosis 💬 1 gene, 1 drug (DrugBank) and 5 diseases |
MMP9 [1] MMP9 💬
|
Andecaliximab Andecaliximab 💬
| Andecaliximab | 046 [5] 46, 96, 97, 272, 299 💬
|
| 9 | MicroRNAs in cancer 💬 1 gene, 1 drug (DrugBank) and 5 diseases |
MMP9 [1] MMP9 💬
|
Andecaliximab Andecaliximab 💬
| Andecaliximab | 046 [5] 46, 96, 97, 272, 299 💬
|
| 10 | Pathways in cancer 💬 1 gene, 1 drug (DrugBank) and 5 diseases |
MMP9 [1] MMP9 💬
|
Andecaliximab Andecaliximab 💬
| Andecaliximab | 046 [5] 46, 96, 97, 272, 299 💬
|
| 11 | Prostate cancer 💬 1 gene, 1 drug (DrugBank) and 5 diseases |
MMP9 [1] MMP9 💬
|
Andecaliximab Andecaliximab 💬
| Andecaliximab | 046 [5] 46, 96, 97, 272, 299 💬
|
| 12 | Proteoglycans in cancer 💬 1 gene, 1 drug (DrugBank) and 5 diseases |
MMP9 [1] MMP9 💬
|
Andecaliximab Andecaliximab 💬
| Andecaliximab | 046 [5] 46, 96, 97, 272, 299 💬
|
| 13 | Relaxin signaling pathway 💬 1 gene, 1 drug (DrugBank) and 5 diseases |
MMP9 [1] MMP9 💬
|
Andecaliximab Andecaliximab 💬
| Andecaliximab | 046 [5] 46, 96, 97, 272, 299 💬
|
| 14 | TNF signaling pathway 💬 1 gene, 1 drug (DrugBank) and 5 diseases |
MMP9 [1] MMP9 💬
|
Andecaliximab Andecaliximab 💬
| Andecaliximab | 046 [5] 46, 96, 97, 272, 299 💬
|
| 15 | Transcriptional misregulation in cancer 💬 1 gene, 1 drug (DrugBank) and 5 diseases |
MMP9 [1] MMP9 💬
|
Andecaliximab Andecaliximab 💬
| Andecaliximab | 046 [5] 46, 96, 97, 272, 299 💬
|
